CGI Pharmaceuticals, Inc. is a private, development-stage pharmaceutical company that has leveraged its proprietary chemistry and kinase biology expertise to discover and develop an innovative pipeline of small molecule therapeutics for multiple oncology and immunology-based indications.  Founded out of Yale University in 2000, CGI's corporate headquarters and research laboratories are located in Branford, Connecticut.